ABSTRACT
Mutant B.4.1 , generated via EMS mutagenesis in Drosophila melanogaster , was studied by undergraduate students participating in the Fly-CURE. After inducing genetically mosaic tissue in the adult eye, B.4.1 mutant tissue displays a robust increase in cell division and a rough appearance. Complementation mapping and sequence analysis identified a nonsense mutation in the gene CG1603 , which we named clifford ( cliff ) due to observed increases in red-pigmented mutant tissue compared to controls. cliff encodes a zinc finger-containing protein implicated in transcriptional control. RNAi knockdown of cliff similarly results in rough eyes, confirming a role for Cliff in eye development.
ABSTRACT
Introducción: La pandemia por COVID-19ha tenido un importante impacto en todos los ámbitos; uno de los más afectados ha sido la sanidad. La pandemia ha supuesto una reorganización de los recursos tanto humanos como materiales, dada la saturación del sistema sanitario. Como especialistas en el cáncer de mama hemos tenido que adaptarnos a esta situación, reorganizando y ajustando los cuidados a los medios profesionales e infraestructuras de los que disponíamos en cada momento. La incidencia variable a lo largo del año ha permitido desarrollar una actividad normalizada en algunas ocasiones. Nos proponemos describir nuestra experiencia en la cirugía del cáncer de mama durante este año de pandemia de COVID-19.Material y métodos: Estudio observacional retrospectivo de pacientes intervenidas de neoplasia de mama desde el 14 de marzo de 2020 hasta el 14 de marzo de 2021.Resultados: Se han intervenido 138 neoplasias de mama en 136 mujeres.La edad media fue de 62 años (36-88). Hubo 86 pacientes (63,2%) en régimen de cirugía mayor ambulatoria y 50 pacientes (36,8%) con ingreso. El tiempo medio desde el diagnóstico hasta la visita en consultas externas fue de 5,7 días y el tiempo medio desde el diagnóstico hasta el inicio del tratamiento de 45 días.Conclusiones: Durante este año de pandemia de COVID-19 hemos podido asegurar la asistencia y tratamiento de las mujeres con cáncer de mama con adecuados intervalos entre el diagnóstico y el tratamiento. A este proceso ha contribuido la implementación previa de la cirugía mayor ambulatoria en el cáncer de mama. (AU)
Introduction: The COVID-19 pandemic has had an important impact in all areas; health service has been one of the most affected. The pandemic has led to a reorganization of human and material resources and has caused a saturation of the health service. As specialists in breast cancer, we have adapted to this situation by reorganizing and adapting care to the professional environments and infrastructures that were available when necessary. The incidence has varied during 2020 and it has made possible to normalize the work on some occasions. We would like to describe our experience in breast cancer surgery during this COVID-19 pandemic year.Material and methods: Retrospective observational study of patients operated on breast cancer from 14th March 2020 to 14th March 2021.Result: A number of 138 breast cancer have been operated on 136 women. The average age is 62 years (36-8); there were 86 patients operated on major ambulatory surgery regimen (63.2%) and 50 patients (36.8%) were hospitalized. The average time from diagnosis to outpatient visit was 5.7 days and the average time from diagnosis to the beginning of the treatment of 45 days.Conclusions: During this COVID-19 pandemic year, we have been able to ensure the care and treatment of women with breast cancer with adequate time intervals between diagnosis and treatment. This process has also been favored by the prior establishment of major ambulatory surgery in our medical center.
